Masahiko Morioka

miR‐200c‐3p spreads invasive capacity in human oral squamous cell carcinoma microenvironment

Tomoyo Kawakubo‐Yasukochi, Masahiko Morioka, Mai Hazekawa et al. · Molecular Carcinogenesis · 2017 · 72 citations · Full text

Medicine, Cancer Biology, Oncology +17

Design, synthesis, and biological evaluation of novel estradiol–bisphosphonate conjugates as bone-specific estrogens

Masahiko Morioka, Akihito Kamizono, Hirosato Takikawa et al. · Bioorganic & Medicinal Chemistry · 2009 · 41 citations

Medicine, Endocrinology, Medicinal Chemistry +16

3-Cyano-6-(5-methyl-3-pyrazoloamino)pyridines: Selective Aurora A kinase inhibitors

Ryoichi Ando, Hiroshi Ikegami, Makoto Sakiyama et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 26 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +10

Tumor‐suppressive roles of ΔNp63β‐miR‐205 axis in epithelial–mesenchymal transition of oral squamous cell carcinoma via targeting ZEB1 and ZEB2

Yuma Hashiguchi, Shintaro Kawano, Yuichi Goto et al. · Journal of Cellular Physiology · 2017 · 22 citations · Full text

Medicine, Cancer Biology, Oncology +17

Synthetic Studies of Amphotericin B. III. An Enantiospecific Synthesis of the C-1–C-19 Segment of the Amphotericin B Aglycon

Mitsuhiro Kinoshita, Masato Taniguchi, Masahiko Morioka et al. · Bulletin of the Chemical Society of Japan · 1988 · 19 citations

Natural Sciences, Chemistry, Medicinal Chemistry +8